TITLE

Identification of sulfation sites of metabolites and prediction of the compounds’ biological effects

AUTHOR(S)
Lin Yi; Dratter, Joe; Chao Wang; Tunge, Jon A.; Desaire, Heather
PUB. DATE
November 2006
SOURCE
Analytical & Bioanalytical Chemistry;Nov2006, Vol. 386 Issue 3, p666
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Characterizing the biological effects of metabolic transformations (or biotransformation) is one of the key steps in developing safe and effective pharmaceuticals. Sulfate conjugation, one of the major phase II biotransformations, is the focus of this study. While this biotransformation typically facilitates excretion of metabolites by making the compounds more water soluble, sulfation may also lead to bioactivation, producing carcinogenic products. The end result, excretion or bioactivation, depends on the structural features of the sulfation sites, so obtaining the structure of the sulfated metabolites is critically important. We describe herein a very simple, high-throughput procedure for using mass spectrometry to identify the structure—and thus the biological fate—of sulfated metabolites. We have chemically synthesized and analyzed libraries of compounds representing all the biologically relevant types of sulfation products, and using the mass spectral data, the structural features present in these analytes can be reliably determined, with a 97% success rate. This work represents the first example of a high-throughput analysis that can identify the structure of sulfated metabolites and predict their biological effects.
ACCESSION #
22458628

 

Related Articles

  • High-Resolution Mass Spectrometry: An Ideal Analytical Tool for Drug Metabolism Studies. Cen Xie; Xiaoyan Chen; Dafang Zhong; Kate Yu // LC-GC North America;Sep2013, Vol. 31 Issue 9, p784 

    The article focuses on high-resolution mass spectrometry (HR-MS) and its application as an analytical tool for drug metabolism. It discusses general strategy of metabolite profiling by HR-MS and several data mining tools such as mass defect filter, precursor ion filter and neutral loss filter....

  • Identification of metabolite's produced by Phanerochaete chrysosporium in the presence of amlodipine orotate using metabolomics. De Sotto, R. B.; Kim, K. I.; Kim, S.; Song, K. G.; Park, Y. // Water Science & Technology;2015, Vol. 72 Issue 7, p1140 

    Pharmaceuticals are very useful in treating human diseases but they are excreted to the environment sometimes in their original form or as byproducts of human metabolism. Pharmaceuticals and their metabolites have been proven by studies to be harmful to non-target ecological species and may be...

  • Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts. Tianxiu Qian; Zongwei Cai // Chinese Medicine;2010, Vol. 5, p19 

    Background: Ginsenosides such as Rb1, Rg3 and Rh2 are major bioactive components of Panax ginseng. This in vivo study investigates the metabolic pathways of ginsenosides Rb1, Rg3 and Rh2 orally administered to rats. Methods: High performance liquid chromatography-mass spectrometry (LC-MS) and...

  • Metabolomics: current state and evolving methodologies and tools. Oldiges, Marco; Lütz, Stephan; Pflug, Simon; Schroer, Kirsten; Stein, Nadine; Wiendahl, Christiane // Applied Microbiology & Biotechnology;Sep2007, Vol. 76 Issue 3, p495 

    In recent years, metabolomics developed to an accepted and valuable tool in life sciences. Substantial improvements of analytical hardware allow metabolomics to run routinely now. Data are successfully used to investigate genotype–phenotype relations of strains and mutants. Metabolomics...

  • Drug Metabolism in Human Brain: High Levels of Cytochrome P4503A43 in Brain and Metabolism of Anti- Anxiety Drug Alprazolam to Its Active Metabolite. Agarwal, Varsha; Kommaddi, Reddy P.; Valli, Khader; Ryder, Daniel; Hyde, Thomas M.; Kleinman, Joel E.; Strobel, Henry W.; Ravindranath, Vijayalakshmi // PLoS ONE;2008, Vol. 3 Issue 6, p1 

    Cytochrome P450 (P450) is a super-family of drug metabolizing enzymes. P450 enzymes have dual function; they can metabolize drugs to pharmacologically inactive metabolites facilitating their excretion or biotransform them to pharmacologically active metabolites which may have longer half-life...

  • Pharmacogenetics, Regulation and Structural Properties of the Drugmetabolizing Enzymes Arylamine N-acetyltransferases. Dupret, Jean-Marie; Dairou, Julien; Atmane, Noureddine; Rodrigues-Lima, Fernando // Current Pharmacogenomics;Dec2004, Vol. 2 Issue 4, p333 

    Xenobiotic-metabolizing enzymes (XME) are responsible for the biotransformation of a vast range of compounds. Arylamine N-acetyltransferases (NAT) are XME responsible for the acetylation of many arylamine and heterocyclic amines. They therefore, play an important role in the detoxification and...

  • Biotransformation. Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p91 

    The article presents an encyclopedia entry for biotransformation. Biotransformation refers to the process that converts liphophilic chemicals to watersoluble metabolites in general. The physical properties of the xenobiotics are changed from those favoring absorption to those favoring excretion....

  • Oxidative Metabolism of BDE-99 by Human Liver Microsomes: Predominant Role of CYP2B6. Erratico, Claudio A.; Szeitz, András; Bandiera, Stelvio M. // Toxicological Sciences;Oct2012, Vol. 129 Issue 2, p280 

    Hydroxylated polybrominated diphenyl ethers (PBDEs) have been found in human serum, suggesting that they are formed by in vivo oxidative metabolism of PBDEs. However, the biotransformation of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE-99), a major PBDE detected in human tissue and...

  • In Vitro and In Vivo Metabolism of a Gamma-Secretase Inhibitor BMS-299897 and Generation of Active Metabolites in Milligram Quantities with a Microbial Bioreactor. Donglu Zhang; Hanson, Ronald; Roongta, Vikram; Dischino, Douglas D.; Qi Gao; Sloan, Charles P.; Polson, Craig; Keavy, Daniel; Ming Zheng; Mitroka, James; Yeola, Suresh // Current Drug Metabolism;Dec2006, Vol. 7 Issue 8, p883 

    BMS-299897 is a γ-secretase inhibitor that has the potential for treatment of Alzheimer’s disease. The metabolism of [14C]BMS-299897 was investigated in human liver microsomes, in rat, dog, monkey and human hepatocytes and in bile duct cannulated rats. Seven metabolites (M1-M7) were...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics